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Objective 
To investigate the effect of liver cell injury markers in clustered risk assessment model for 
identification of children at risk of cardiometabolic disease 
Design/Setting 
This cross-sectional observational study was carried out in primary schools in Liverpool and 
Ulster, UK. Participants were 10-12 year old healthy schoolchildren who underwent 
anthropometric measurements, phlebotomy, cardiorespiratory fitness and physical exercise 
assessments. 
Main outcome measures 
The main outcome measures included assessment of high and low cardiometabolic risk 
participants through a clustered risk score model, which incorporated covariates implicated 
in the pathogenesis of the metabolic syndrome: body mass index, waist circumference, 
blood pressure, proinflammatory cytokines, markers of systemic inflammation, liver cell injury 
markers, lipid profile, cardiorespiratory fitness and time spent in activity. 
Results 
Children classified as fit or active have lower cardiometabolic risk than their ‘unfit’ or 
‘inactive’ peers.  This fact remained unchanged whether markers of hepatocyte injury were 
included in the clustered risk assessment model or not.  
Conclusions 
The clustered risk score model is a non-invasive and scientifically robust method of 
cardiometabolic risk assessment in childhood, which reiterates the importance of weight 
reduction and promotion of cardiorespiratory fitness from childhood.  Our study did not show 
any significant contribution of liver cell injury markers, however larger scale research is 
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needed so as to fully evaluate the effect of these widely used markers in early 
cardiometabolic risk stratification in children. 
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Introduction 
According to the recent new worldwide definition by Eckel et al (1), metabolic syndrome 
(MS) is characterized by accumulation of visceral fat and is associated with the clustering of 
metabolic and pathophysiological cardiovascular risk factors such as impaired glucose 
tolerance, dyslipidaemia, and hypertension.  MS is a condition with increased morbidity 
which may have its origin as early as childhood (2, 3). 
A growing body of evidence suggests that increased oxidative stress to adipocytes is central 
to the pathogenesis of cardiovascular disease in MS (4). Increased oxidative stress to 
adipocytes causes dysregulated expression of inflammation-related adipocytokines; this 
contributes to obesity-associated vasculopathy and cardiovascular risk, primarily through 
endothelial dysfunction.        
Non-alcoholic liver fatty disease (NAFLD) is a recognised severe hepatic manifestation of 
MS with increasing prevalence in obese children (5).  Higher BMI, significantly and 
independently of other risk factors, increases the chances of having liver inflammation and 
fibrosis in children, (6) which may be present but asymptomatic from as early as childhood 
(7). 
Cardiorespiratory fitness (CRF) is a functional measure of the cardiorespiratory system and 
an independent predictor of cardio-metabolic morbidity in children (8-11).  CRF has however 
received little attention from policy makers in comparison to obesity (12).  Levels of 
cardiorespiratory fitness in children have declined in recent years, independent of changes in 
body size and/or excessive adiposity (13).  Numerous papers have described links between 
measures of CRF, habitual physical activity (PA) and metabolic risk in children and 
adolescents (14).  Studies have shown that overweight fit children are at lesser risk for MS 
than overweight unfit children (15).  
A number of studies have suggested the potential value of novel serum biomarkers, such as 
high sensitivity C-reactive protein (hs CRP) (16), adiponectin (17) and homeostasis model of 
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insulin resistance (HOMA-IR) (18, 19), to detect early stages of MS.  Conventional markers 
of liver cell injury such as aspartate aminotransferase (AST), alanine aminotransferase (ALT) 
and gamma-glutamyl transpeptidase (GGT) have however not been included  in validated 
assessment models of cardiometabolic risk (20), despite the recognised association 
between MS and liver pathology (NAFLD).   
Aim  
The aim of this study was to investigate the clustered cardiometabolic risk scores in healthy 
10-12 year olds by using anthropometric characteristics, reference standard measurements 
of CRF and PA, and laboratory blood markers of metabolic disease.  In addition, we aimed 
to evaluate how inclusion of markers of liver cell injury may affect the clustered 
cardiometabolic risk assessment model.  
Methods 
Data were generated by the REACH Year 6 study, which was a collaborative observational 
study conducted in Liverpool and Ulster UK.  The methods for the REACH Year 6 study 
have been described previously (21). After gaining local NHS and institutional ethical 
approvals, parental consent and participant assent, participants took part in one laboratory 
and one school based testing session and wore accelerometers to monitor habitual PA.   
Laboratory measures: Stature and sitting stature to the nearest 0.1cm (Seca Ltd. 
Birmingham, UK), body mass to the nearest 0.1kg (Seca Ltd. Birmingham, UK) and waist 
circumference were assessed using standard techniques (22). Body mass index, BMI Z-
scores(23) and somatic maturation were calculated (years to peak height velocity: YPHV).  
Blood pressure (BP) was assessed after a 15 minute rest period.  After BP measurements, 
nitric oxide-mediated endothelial function was measured by flow mediated dilation (FMD) 
using high resolution ultrasonography after a 5-minute ischemic stimulus (Terason, t3000; 
Aloka, London, UK) (24, 25). FMD % was retained for analysis. 
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CRF (VO2peak) was assessed using an individually calibrated treadmill (H P Cosmos, 
Traunstein, Germany) protocol.  All participants wore a heart rate monitor (Polar, Kempele, 
Finland) and an accelerometer (Actigraph, GT1M, Actigraph LLC, Pensacola, FL, USA) 
throughout the test.  To account for differences in biological age and limb length between 
participants, treadmill speeds were calculated using set Froude (Fr) numbers (21, 25).  
Participants completed 2 minute stages, with stage 1 speed set at Fr 0.25 and stage 2 at Fr 
0.5, each additional speed was then calculated by the difference in speed between the Fr 
0.25 and Fr 0.50, ~2 km/hour increases in speed every two minutes.  VO2peak was defined as 
the highest 15 second averaged oxygen uptake, measured by breath by breath gas analysis 
(Liverpool site: Jaeger Oxycon Pro, Viasys Health Care, Warwick, UK, Ulster site: COSMED, 
Quark, Italy) when the subjective endpoints were met (respiratory exchange ratio >1.05, 
and/or heart rate >199 beats/min).  Participants were classified as fit or unfit using published 
thresholds (26). 
School-based blood sampling:  
After verbal confirmation of overnight fast venous blood samples were drawn between 8.30-
10.30 am by experienced phlebotomists.  Samples were transported to Alder Hey Children’s 
NHS Foundation Trust or Ulster Hospital for analysis.  Total cholesterol, high density 
lipoprotein cholesterol (HDL-c), triglycerides, glucose, hs CRP, adiponectin, ALT, AST and 
GGT were retained in this study for analysis.  
PA monitoring: 
Habitual PA was assessed using a uniaxial accelerometer, which is a valid and reliable 
method of assessing PA in children (9). Monitors were distributed at school and worn on the 
right hip for seven days using a five second data collection epoch.  Sustained bouts of ≥ 20 
minutes of zero counts were subtracted from wear time (27).  Minimum wear time was ≥9 
hours for ≥3 days (28). Data were analysed using individually calibrated thresholds.  The 
thresholds were generated from the VO2peak protocol and this approach has been described 
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previously (29).  A sedentary threshold was set at 100 counts per minute (30), and time 
spent between Fr 0.25 to Fr 0.5 (moderate intensity PA), and ≥ Fr 0.5 (vigorous intensity PA) 
was established. Mean sedentary time and time spent at ≥ Fr 0.25 (moderate to vigorous 
intensity PA: MVPA) were retained for analysis.  Accelerometer wear time was retained as a 
covariate within analysis.  Participants were classified as active (MVPA ≥60 minutes, inactive 
(MVPA < 60 minutes).  
 
Clustered cardiometabolic risk scores: 
Clustered risk scores account for the constellation of factors associated with cardiometabolic 
disease, are less sensitive to daily fluctuations in individual markers and are widely used in 
empirical research (13, 21). To calculate clustered risk scores risk markers were 
standardised by sex and then summed.  Data for boys and girls were then re-combined and 
analysed together to maximise statistical power.  Prior to standardisation the following 
variables were not normally distributed and were log transformed: waist circumference, 
systolic and diastolic BP (girls only), HDL-c (girls only), glucose, CRP, ALT (girls only), AST 
(girls only). 
Two clustered cardiometabolic risk scores were calculated.  Clustered risk score 1 included: 
waist circumference, systolic BP, diastolic BP, FMD % (inverted), triglycerides, HDL-c 
(inverted), glucose, CRP and adiponectin (inverted). Clustered risk score 2 included the 
same variables with the addition of ALT, AST and GGT.  Participants with clustered risk 
score ≥1SD above the grand mean were classified as at risk. 
 
Statistical Analysis: 
One way ANOVA was completed to assess differences in markers between girls and boys.  
For the main analysis MANCOVAs were completed to assess differences in BMI Z-score, 
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VO2peak, MVPA and sedentary time by clustered risk group, this was completed in two 
models, one for clustered risk score 1 and one for clustered risk score 2, controlling for sex, 
maturation and accelerometer wear time.  ANCOVA was completed to assess differences in 
clustered risk scores by fitness status (controlling for sex and maturation) and activity status 
(controlling for sex, maturation and accelerometer wear time). Partial correlations were 
conducted to assess the relationship between clustered risk score, BMI Z-score, VO2peak, 
MVPA and sedentary time controlling for sex, maturation and accelerometer wear time.  
 
Results 
Table 1 shows the descriptive characteristics of the study participants by sex.  One way 
ANOVA revealed that VO2peak and MVPA were significantly greater in boys than girls 
(p<0.05).  CRP and triglycerides were significantly higher in girls than boys.  Non significant 
differences between sexes were observed for BMI Z-score, waist circumference, cholesterol, 
AST, ALT, adiponectin, sedentary time and clustered risk scores. The prevalence of obesity 
and overweight according to Cole et al (31) is demonstrated in Table 2. 
Main analysis 
Tables 3&4 show the results of MANCOVA between low and high risk participants, 
controlling for YPHV, sex and accelerometer wear time.  In both clustered risk models similar 
differences were observed; BMI Z score and VO2peak were significantly different between the 
risk subgroups.  MVPA and sedentary time did not differ between the high and low risk 
groups. 
Table 5 displays the results of the ANCOVA. Fit participants had significantly lower clustered 
risk scores than their unfit counterparts (p<0.01). Similarly, active children displayed 
significantly lower clustered cardiometabolic risk scores than the inactive group.  
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Both clustered risk scores demonstrated positive, moderate correlations with BMI Z score 
(r=+0.622 and r= +0.522 respectively).  The negative correlation between clustered risk 
scores 1&2 and VO2peak was weaker (r=-0.241, r=-293) (Tables 6&7). 
Sedentary time was negatively correlated with VO2peak (r=-0.45, p<0.001).  On the contrary 
MVPA was positively correlated (r=+0.442, p<0.001) with VO2peak (Table 6).  Correlations 
were weaker when liver function tests were included in the clustered risk assessment model 
(Table 7). 
Discussion 
With regards to baseline differences between the two sexes, MVPA and VO2peak were 
significantly higher in boys (p<0.05), which is in line with results from recent longitudinal 
studies (32) (33). Laboratory parameters such as triglycerides and CRP were significantly 
higher in girls (p<0.05).  This finding may be characteristic of our sample population; notably 
the prevalence of overweight/obese females in our study population was higher than in 
males. Despite above differences, clustered risk scores were comparable between the two 
sexes. 
Statistically significant differences for both types of clustered risk score were noted between 
the active and inactive subgroups, and the fit and unfit groups.  This reiterates that both 
fitness and physical activity are important in cardiometabolic risk assessment, and that more 
active or fit children are at significantly lower risk of cardiometabolic morbidity.  Interestingly 
MVPA and sedentary times were not significantly different between high and low risk 
subgroups, when analyses were controlled for sex, maturation and accelerometer wear time.  
These results are in keeping with findings from recent studies by Ried-Larsen et al (34) and 
Lopez Martinez et al (35).  These studies additionally advocate that high volume or more 
time spent in vigorous physical activity may be independently associated with lower 
metabolic risk, and may compensate for time spent in sedentary, low or moderate intensity 
activity.  The inclusion of markers of liver cell injury tests, namely AST, ALT and GGT as 
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additional components in the clustered risk model did not significantly alter the findings in our 
risk assessment model. Therefore AST, ALT and GGT values were not indicative of 
increased risk in our study population and did not significantly add to the predictive value of 
our clustered risk assessment model.  This finding can be interpreted in more than one ways.  
Firstly, our sample size may not be large enough to allow us to detect possible effect of liver 
function tests on the clustered risk assessment model.  Another possible explanation is that 
cardiometabolic risk may be independent of liver cell injury markers in mid childhood. 
It is important to emphasise that the clustered risk values estimated in both models were 
consistently and more strongly correlated with BMI Z-score than any other parameter 
investigated.  This is not proof of causality, but reiterates the fact that BMI Z-scores play a 
definitive role in mid childhood risk assessment of cardiometabolic disease, therefore 
childhood weight reduction interventions are of high importance.   
CRF was negatively correlated with risk and fit children were at reduced metabolic risk. This 
finding emphasises the independent role of this parameter in risk assessment process and 
the attention that should be drawn to fitness promotion from childhood.  
PA activity promotion is essential, as the modifiable component of CRF is the product of 
recent MVPA, whereas adiposity may be significantly reduced by MVPA through energy 
expenditure. A recent systematic review has also highlighted the beneficial effect of direct 
delivery of physical activity on fitness and cardiometabolic markers in children and 
adolescents, through school based interventions (36).  
This study is limited by a number of factors.  Primarily this is a cross-sectional study with a 
limited sample size.  Findings may not be generalizable before larger scale implementation 
in different populations with genetic and cultural variations, and matched controls.  
The major strength of this study is the implementation of a previously validated clustered risk 
assessment tool which incorporates relevant anthropometric, functional and laboratory 
parameters.  All measurements were performed in a reproducible, scientific manner, with the 
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use reference standard methods.  The novel parameters assessed in this study were 
conventional markers of liver cell injury which clearly did not appear to significantly add to 
the cardiometabolic risk stratification of healthy 10-12 year old schoolchildren.  To our 
knowledge this is the first study to address the effect of inclusion of standard markers of liver 
cell injury in a cardiometabolic clustered risk score model in mid childhood.  In alignment to 
other studies highlighting the importance of physical activity and fitness, further longitudinal 
cohort studies are required to investigate the impact of physical activity in prevention of the 
metabolic syndrome and associated co-morbidities. 
Conclusion 
Children classified as fit and active exhibited lower clustered cardiometabolic risk scores 
when compared to their unfit or inactive peers; this fact remained unchanged whether 
markers of liver cell injury were or were not included in the clustered risk assessment model.  
Emphasis must be given to weight optimisation and cardiorespiratory fitness promotion 
through physical activity from childhood, to effectively decrease the risk of cardiometabolic 
disease in life. 
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What is already known on this topic?  
Cardiometabolic disease begins in childhood, and early detection of those at increased risk 
would be of significant public health benefit. 
Cardiorespiratory fitness and body mass index are independent predictors of 
cardiometabolic morbidity in children.  
Clustered risk scores are used in empirical research and provide a robust methodology for 
pragmatic cardiometabolic risk stratification in childhood. 
What this study adds 
Children classified as fit or active have lower cardiometabolic risk scores compared to their 
unfit and inactive peers. 
This is the first study to incorporate liver cell injury markers within a cardiometabolic risk 
score in children, which did not significantly alter observed relationships. 
This study provides more evidence regarding the importance of physical activity promotion to 
improve cardiorespiratory fitness, body size and subsequent cardiometabolic disease risk in 
children. 
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Tables 
 Boys  Girls   
Variable Mean Number Mean  Number p 
Waist 
circumference  
62.98 [6.2] 45 65.60 [9.4] 54 0.11 
BMI Z-score 0.28 [0.94] 45 0.49 [1.28] 54 0.36 
VO2peak 47.34 [9.93] 43 41.19 [8.59] 52 <0.01* 
Systolic BP 104.32 
[12.25] 
44 102.86 [12.21] 51 0.56 
Diastolic BP 62.66 [5.66] 44 62.94 [7.59] 51 0.84 
FMD% 7.78 [3.36] 39 8.32 [4.06] 45 0.51 
CRP 0.40 [0.40] 42 0.88 [1.27] 51 0.02† 
AST 25.57 [4.47] 42 24.10 [5.0] 51 0.14 
Triglycerides 0.62 [0.20] 42 0.79 [0.30] 51 0.01† 
ALT 16.14 [3.35] 42 16.84 [4.96] 51 0.44 
Cholesterol 4.07 [0.65] 42 4.22 [0.57] 51 0.25 
HDL-c 1.56 [0.29] 42 1.48 [0.39] 51 0.33 
Glucose 4.68 [0.32] 42 4.63 [0.30] 51 0.42 
Adiponectin 11.12 [5.21] 42 11.22 [6.27] 51 0.94 
Sedentary Time 494.07 
[78.00] 
39 520.05 [59.77] 49 0.08 
MVPA 59.70 [29.71] 39 47.24 [21.28] 44 0.03* 
Clustered Risk 1 0.05 [3.90] 36 -0.29 [3.85] 44 0.70 
Clustered Risk 2 0.02 [4.63] 36 -0.26 [4.08] 44 0.78 
Table 1: Descriptive statistics: Untransformed mean [SD] one-way ANOVAs by sex 
  Boys (n = 45)   Girls (n= 54)   
 BMI Total number Prevalence Total number Prevalence 
Overweight (85th-
95th centile) 
5 11.1% 15 27.8 
Obese (>95th 
centile) 
1 2.2% 5 9.3% 
Table 2:  Prevalence of obese and overweight children as defined by Cole et al31 
Clustered risk score 
2 
High Risk (n =9) Low Risk (n = 46) p value 
BMI Z-score 1.30 [0.32] 0.25 [0.14] 0.005 
VO2peak 35.74 [2.78] 43.09 [1.18] 0.02 
MVPA 45.47 [8.71] 51.01 [3.69] 0.566 
Sedentary Time 544.67 [15.05] 519.07 [6.39] 0.130 
Table 3: MANCOVA (controlling for sex, YPHV, accelerometer wear time) between high and 
low risk groups: clustered risk score 2 (includes liver tests). Risk is defined as ≥1SD above 
the grand mean for the relevant clustered risk score. 
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Clustered risk score 
1 
High Risk (n =11) Low Risk (n = 56) p value 
BMI Z-score 1.26 [0.32] 0.33 [0.13] 0.009 
VO2peak 36.38 [2.57] 44.31 [1.08] 0.007 
MVPA 42.77 [8.16] 54.15 [3.44] 0.21 
Sedentary Time 527.23 [13.66] 510.18 [5.76] 0.26 
Table 4: MANCOVA (controlling for sex, YPHV, accelerometer wear time) between high and 
low risk groups: clustered risk score 1 (no liver tests).  Risk is defined as ≥1SD above the 
grand mean for the relevant clustered risk score. 
Analysis Unfit [SEM] Fit [SEM] p value Inactive[SEM] Active 
[SEM] 
p value 
Clustered risk 
2 (ANCOVA) 
2.81 [0.79] 
n = 33 
-1.10 
[0.87]= 28 
0.002 1.87 [0.71] N 
= 43 
-1.15 
[1.22] N = 
15 
0.038 
Clustered Risk 
1 (ANCOVA ) 
1.33 [0.57] 
n = 38 
-1.59 [0.57] 
n = 38 
P=0.001 0.57 [0.51] -1.75 
[0.80] 
0.018 
Table 5 ANCOVA: Clustered risk scores 1&2 by fitness and activity status (controlling for sex 
and YPHV) 
Table 6: Partial correlations (controlling for YPHV, sex and accelerometer wear time) 
Table 7: Partial correlations (controlling for YPHV, sex and accelerometer wear time) 
 
 Clustered Risk 
1 
BMI Z-score VO2peak MVPA Sedentary 
Time 
Clustered Risk 
1 
 .622 -.241 -.113 -.075 
(df = 62) P  <.001 .055 .372 .540 
BMI Z-score .622  -.281 -.075 -.052 
P <.001  .024 .558 .683 
VO2peak -.241 -.281  .442 -.452 
P .055 .024  <0.001 <0.001 
MVPA -.113 -.075 .442  -.633 
p .372 .558 <0.001  <0.001 
 Clustered Risk 
2 
BMI Z-score VO2peak MVPA Sedentary 
Time 
Clustered Risk 
2 
 .522 -.293 -.166 .022 
(df = 50) P  <.001 .035 .239 .879 
BMI Z-score .522  -.230 -.007 -.087 
P <.001  .101 .961 .538 
VO2peak -.293 -.230  .320 -.421 
P .035 .101  .021 .002 
MVPA -.166 -.007 .320  -.663 
p .293 .961 .021  <.001 
